Biologics

Spinal Implants

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

BELGRADE, Mont. , May 13, 2024 — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after